Immunome (IMNM) Return on Capital Employed (QoQ) (2021 - 2026)

Immunome (IMNM) Return on Capital Employed (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Immunome 2.49 Bn 1.91 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1,195.00
Dec 31, 2025 3,771.00
Sep 30, 2025 -1,220.00
Jun 30, 2025 796.00
Mar 31, 2025 7,373.00
Dec 31, 2024 -2,347.00
Sep 30, 2024 -3,263.00
Jun 30, 2024 1,540.00
Mar 31, 2024 -609.00
Dec 31, 2023 -5,932.00
Sep 30, 2023 9,322.00
Jun 30, 2023 11,967.00
Mar 31, 2023 -7,936.00
Dec 31, 2022 -5,001.00
Sep 30, 2022 -3,081.00
Jun 30, 2022 -2,756.00
Mar 31, 2022 -2,655.00
Dec 31, 2021 -1,134.00
Sep 30, 2021 -540.00
Jun 30, 2021 148.00